NASDAQ: AMPH
Amphastar Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
After hours: $20.79(+0.05%) · as of 7:52 PM ET
Market Cap
$916.25M
52w High
$31.26
52w Low
$16.65
P/E
11.70
Volume
1.26M
Outstanding Shares
44.09M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock fell 3.89% over the last year. Revenue grew 1.35% over the trailing twelve months. Operating margin moved from 25.22% to 15.66%. Free cash flow grew 70.45% over the trailing twelve months.
What the market seems to be pricing
The stock has moved lower against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 15.66%. A decisive move in revenue — currently up 1.35% — would be the clearest signal to resolve the ambiguity.
Company profile
Amphastar Pharmaceuticals, Inc., established in 1996 and based in Rancho Cucamonga, California, functions as a biopharmaceutical enterprise.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
3
Buy
8
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est $0.79 · Revenue est $197.78M
View